Database of Data Collection
Launched by INSTITUT PAOLI-CALMETTES · Mar 5, 2018
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Database of Data Collection" is focused on gathering information about women who have undergone surgery for breast cancer. The goal is to collect and analyze data from patients who have been diagnosed with breast cancer and have had surgical treatment. This information will help researchers understand more about the condition and improve future care for patients.
To be eligible for this study, participants must be women aged 18 and older who have had surgery for confirmed breast cancer. If you join the study, you’ll be contributing to a valuable database that can aid in breast cancer research. It’s important to note that the trial is currently recruiting participants. If you or someone you know fits the criteria, this could be an opportunity to help advance knowledge about breast cancer treatment.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • patients operated for histologically proven breast cancer.
- Exclusion Criteria:
- • Patient below age of 18 years
About Institut Paoli Calmettes
Institut Paoli-Calmettes (IPC) is a leading cancer research and treatment center located in Marseille, France, dedicated to advancing oncology through innovative clinical trials and comprehensive patient care. With a multidisciplinary approach, IPC integrates cutting-edge research, education, and clinical services to enhance cancer prevention, diagnosis, and treatment. The institute is committed to fostering collaboration among researchers, healthcare professionals, and patients, aiming to translate scientific discoveries into effective therapeutic strategies. As a recognized institution in the field of oncology, IPC plays a pivotal role in shaping the future of cancer care and improving patient outcomes through rigorous and ethical clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marseille, Bouches Du Rhone, France
Patients applied
Trial Officials
Gilles HOUVENAEGHEL
Principal Investigator
Institut Paoli-Calmettes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials